Clinical Trial Update: Safety Study of BLZ-100 in Adult Subjects With Sarcoma Undergoing Surgery [Phase 1]

View source ↗

Summary

The Phase 1 safety study of BLZ-100 in adults with soft tissue sarcoma undergoing surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• BLZ-100

Snippet

Sponsor: Blaze Bioscience Inc. | Conditions: Sarcoma, Soft Tissue | Phase 1 | Status: WITHDRAWN